Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
DIACHIRO: D-Chiro-Inositol and Metformin for Insulin Resistance in T2DM
NCT06860841Phase 4Active, not recruiting
- Sponsor
- Università Campus Bio-Medico di Roma
- Start
- Jan 2025
- Primary completion
- Feb 2025
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 4 trial of bCalm in type 2 diabetes mellitus (T2DM), obesity, sponsored by Università Campus Bio-Medico di Roma. Started Jan 2025; status: active, not recruiting.
02
Drugs
bCalm
03
Conditions
type 2 diabetes mellitus (T2DM)obesity
Beyond the preview
Go deeper on NCT06860841.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT06860841.